|
tbar.gif
Click
here to
submit entries
|
|
|
Merck
& Co. Teaming With Dana-Farber on Cancer Drug Development |
February
12, 2008--The Center for Applied Cancer Science (CACS) of the
Dana-Farber Cancer Institute and Merck & Co. have established a
collaboration to identify promising drug targets, and develop therapeutic
candidates to reach those targets. Under the agreement, Merck will provide
up-front and research support funding to the CACS as well as milestone and
royalty payments upon market approval. Dana-Farber
Cancer Institute
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
